Clinical Trial Update: Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ALKS 3831 reporting long-term safety, tolerability, and durability of treatment effect; results have been posted after complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• ALKS 3831

Snippet

Sponsor: Alkermes, Inc. | Conditions: Schizophrenia, Schizophreniform Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-09-26